US Edition
Eyestem secures $10m to advance cell therapy for advanced eye disease - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Eyestem secures $10m to advance cell therapy for advanced eye disease - Pharmafile
Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal pigment cell therapy, Eyecyte-RPE, for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The funding will allow for the completion of an ongoing phase 2 clinical trial in India and preparations for an […] The post Eyestem secures $10m to advance cell therapy for advanced eye diseas…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
